A61K 38/1841
Transforming growth factor [tgf]
Official title: {Transforming growth factor [TGF]}
A61K38/1841 (Transforming growth factor [tgf]) appears on 781 US grants and 1,294 published applications in this corpus.
Search patents in A61K- Granted patents
- 781
- Published applications
- 1,294
- Assignees
- 617
- Inventors
- 1,959
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 7 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 11 | 0 |
| 1996 | 4 | 0 |
| 1997 | 19 | 0 |
| 1998 | 20 | 0 |
| 1999 | 17 | 0 |
| 2000 | 13 | 0 |
| 2001 | 13 | 2 |
| 2002 | 9 | 22 |
| 2003 | 13 | 25 |
| 2004 | 7 | 24 |
| 2005 | 6 | 29 |
| 2006 | 11 | 46 |
| 2007 | 11 | 45 |
| 2008 | 14 | 68 |
| 2009 | 13 | 47 |
| 2010 | 21 | 58 |
| 2011 | 14 | 74 |
| 2012 | 51 | 43 |
| 2013 | 31 | 76 |
| 2014 | 48 | 87 |
| 2015 | 52 | 82 |
| 2016 | 44 | 62 |
| 2017 | 56 | 59 |
| 2018 | 34 | 53 |
| 2019 | 37 | 57 |
| 2020 | 42 | 51 |
| 2021 | 30 | 56 |
| 2022 | 33 | 67 |
| 2023 | 16 | 50 |
| 2024 | 27 | 44 |
| 2025 | 28 | 40 |
| 2026 | 14 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Growth and differentiation factor 15 for treatment of proliferative vitreoretinopathy therapy8 Sep 2026US 12,728,152 B2The Board of Trustees of the Leland Stanford Junior University
- Hyaluronic composition30 Jun 2026US 12,667,594 B2Vivex Biologics Group, Inc.
- Bioengineered scaffolds for modulation of immune system and the uses thereof23 Jun 2026US 12,661,433 B2President and Fellows of Harvard College
- Treatment of intervertebral disc degeneration16 Jun 2026US 12,653,842 B2Kolon Tissuegene, Inc.
- Pharmaceutical composition for preventing or treating osteoarthritis19 May 2026US 12,629,393 B2Kolon Life Science, Inc.
- Method for treating lower back pain1 Oct 2026US 2026/0294974 A1Mesoblast International Sarl
- Treg therapy10 Sep 2026US 2026/0263556 A1Quell Therapeutics Limited
- Recombinant protein compositions useful for wound healing10 Sep 2026US 2026/0263559 A1Wake Forest University Health Sciences
- Compositions and methods of controlling expression of thermogenin (ucp-1) in skeletal muscles10 Sep 2026US 2026/0263560 A1Thermogen Biotherapeutics, LLC
- Treatment of intervertebral disc degeneration3 Sep 2026US 2026/0256847 A1Kolon Tissuegene, Inc.
Most cited
By later US patents
- Three dimensional cell protector/pore architecture formation for bone and tissue constructs778US 7,713,542 B2ADA Foundation · 2010
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone349US 5,270,300 A1993
- Tissue-derived tissuegenic implants, and methods of fabricating and using same329US 8,883,210 B1Musculoskeletal Transplant Foundation · 2014
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000